Granahan Investment Management, LLC Otonomy, Inc. Transaction History

Granahan Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.49 - $6.23 $342,287 - $856,406	-137,465 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.48 - $6.47 $51,918 - $96,525	-14,919 Reduced 9.79%	137,465 $889,000
Q3 2020 Nov 12, 2020	BUY	$3.16 - $4.36 $9,777 - $13,489	3,094 Added 2.07%	152,384 $617,000
Q2 2020 Aug 14, 2020	SELL	$1.87 - $3.84 $30,279 - $62,177	-16,192 Reduced 9.78%	149,290 $540,000
Q1 2020 May 12, 2020	BUY	$1.58 - $4.06 $261,461 - $671,856	165,482 New	165,482 $326,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.